[ Back to EurekAlert! ]

PUBLIC RELEASE DATE:
25-Mar-2014

[ | E-mail ] Share Share

Contact: Jack Stonebridge
jack.stonebridge@kcl.ac.uk
020-784-83238
King's College London
@kingscollegelon

Penicillin prescriptions risk under-dosing children, say experts at King's College London

VIDEO: Millions of children in the UK are potentially receiving penicillin prescriptions below the recommended dose for common infections, according to new research led jointly by researchers at King's College London,...

Click here for more information.

Millions of children in the UK are potentially receiving penicillin prescriptions below the recommended dose for common infections, according to new research led jointly by researchers at King's College London, St George's, University of London and Imperial College London. The authors are calling for an urgent review of penicillin dosing guidelines for children - which at the time of study had not changed in over 50 years - after discovering wide variation in current prescribing practice.

The research adds to growing concern about the global threat of antibiotic resistance, whereby misuse of antibiotics leads to the emergence of bacteria that cannot be controlled by available medicines.

Published today in the British Journal of General Practice, the study is the first to examine actual prescriptions of oral penicillins, the most commonly prescribed antibiotics for children worldwide, by GPs in the UK.

Analysing data from the IMS Disease-Analyzer database, researchers found that of the children under the age of one who were prescribed amoxicillin - the most commonly prescribed oral penicillin - none of them were prescribed the dose recommended (62.5 mg per unit) by the British National Formulary for Children (BNFC). In fact, the majority received double the recommended dose (125 mg).

96 percent of children aged 1-5 received the recommended dose but 40 per cent of 6-12 year olds and 70 per cent of 12-18 year olds were prescribed unit-doses below the BNFC guidelines. Similar patterns of prescribing were found for penicillin V and flucloxacillin.

The study, funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, also looked specifically at prescriptions for ear infection, the most common condition in childhood that can lead to the prescription of oral penicillin, and found that children under the age of one were the only group who received the recommended dose of amoxicillin. For children aged 4-15 years the prescriptions equated to approximately 33 per cent of the recommended dose.

Dosing guidelines for oral penicillin are currently provided by the BNFC and are determined by age and weight-bands. Although guidelines specifically for amoxicillin did change late last year, the authors suggest this has only made the situation worse, particularly in the approval of a new, wider 5-18 age band.

Dr Paul Long, Reader in Pharmacognosy at King's College London, said: '12-18 year olds should have received a 500mg dose based on pre-2013 guidance but our study shows that many of these teenagers were actually prescribed 250mg. Introducing a new 5-18 age band would seemingly justify a 250mg prescribing practice, but actually only further exacerbates potential under-dosing in the 12-18 age group.'

Another problem with the current guidelines, according to the researchers, is that they do not take into account how the average weight of children has changed over time. Due to the rising prevalence of childhood obesity, prescriptions based on age-bands could lead to doses prescribed at too low a level to produce a therapeutic effect (sub-therapeutic dosing).

This new study follows a literature review of evidence in 2011 to understand the origins of dosing guidelines, which found that prescribing based on age-bands had first been suggested in the early 1950s. Following these findings, a general recommendation to use age banding for all antibiotics in children was published in the BMJ in 1963, and these same recommendations remain in use today. This is despite the re-evaluation of guidelines for adult penicillin prescriptions, which did take modern weights into consideration.

The authors attribute wide variation in prescription practice to the complicated nature of current guidelines. Dr Long of King's College London said: 'Although oral penicillins have been widely used for over 50 years to treat infections in children, the dosing guidelines have remained complicated, which carries the risk of confusing prescribers. Age and weight bands are well established but there is no standardised or evidence-based guideline to clarify which method of dose selection is best.

'The need to review these guidelines is more urgent than ever as it is clear from ourresearch that age-banding doses is no longer appropriate.

'A detailed qualitative assessment of prescriber practice is also required to understand reasons for the use of age-bands and the barriers to implementation of weight-based dosing.'

Dr Sonia Saxena, co-author from the School of Public Health, Imperial College London and a practising GP, said: 'It is important now to understand why GPs are prescribing sub-therapeutic levels of penicillin. Some GPs may be erring on the side of caution, prescribing low doses to avoid errors or side effects.'

Dr Saxena added: 'In the majority of cases children will still get better, but undertreating those children who do need antibiotics could mean more infectious complications and more health contacts overall.'

###

For further information please contact Jack Stonebridge, Press Officer at King's College London, on 0207 848 3238 or email jack.stonebridge@kcl.ac.uk

Notes to editors:

King's College London

King's College London is one of the top 20 universities in the world (2013/14 QS World University Rankings), and the fourth oldest in England. A research-led university based in the heart of London, King's has nearly 23,500 students (of whom more than 9,000 are graduate students) from nearly 140 countries, and some 6,000 employees. King's is in the second phase of a £1 billion redevelopment programme which is transforming its estate.

King's has an outstanding reputation for providing world-class teaching and cutting-edge research. In the 2008 Research Assessment Exercise for British universities, 23 departments were ranked in the top quartile of British universities; over half of our academic staff work in departments that are in the top 10 per cent in the UK in their field and can thus be classed as world leading. The College is in the top seven UK universities for research earnings and has an overall annual income of nearly £450 million.

King's has a particularly distinguished reputation in the humanities, law, the sciences (including a wide range of health areas such as psychiatry, medicine, nursing and dentistry) and social sciences including international affairs. It has played a major role in many of the advances that have shaped modern life, such as the discovery of the structure of DNA and research that led to the development of radio, television, mobile phones and radar.

King's College London and Guy's and St Thomas', King's College Hospital and South London and Maudsley NHS Foundation Trusts are part of King's Health Partners. King's Health Partners Academic Health Sciences Centre (AHSC) is a pioneering global collaborationbetween one of the world's leading research-led universities and three of London's most successful NHS Foundation Trusts, including leading teaching hospitals and comprehensive mental health services. For more information, visit: http://www.kingshealthpartners.org.

The National Institute for Health Research (NIHR) is funded by the Department of Health to improve the health and wealth of the nation through research. Since its establishment in April 2006, the NIHR has transformed research in the NHS. It has increased the volume of applied health research for the benefit of patients and the public, driven faster translation of basic science discoveries into tangible benefits for patients and the economy, and developed and supported the people who conduct and contribute to applied health research. The NIHR plays a key role in the Government's strategy for economic growth, attracting investment by the life-sciences industries through its world-class infrastructure for health research. Together, the NIHR people, programmes, centres of excellence and systems represent the most integrated health research system in the world. For further information, visit the NIHR website.



[ Back to EurekAlert! ] [ | E-mail Share Share ]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.